Alzheimer’s disease
-
Alzheimer’s disease, blood biomarkers, Brain, capillary blood sampling, cognition, cognitive impairment, dementia screening, fingerprick test, GFAP, Neurodegenerative Diseases, neuroscience, p-tau217, PROTECT study, remote testingAlzheimer’s Fingerprick Blood Biomarkers: p-tau217 and GFAP Track Cognition
A 2026 PROTECT study involving 174 older adults found that self-administered fingerprick…
-
Alzheimer’s disease, ApoB, blood test, Brain, C1QA, clusterin, Dementia, mild cognitive impairment, Neurodegenerative Diseases, neuroscience, plasma biomarkers, protein structureAlzheimer’s Plasma Protein Structure Panel Reached AUCs Above 0.93
A 2026 Nature Aging study involving 520 participants found that plasma protein-structure…
-
Alzheimer’s disease, bioinformatics, Brain, cdk5, EFNA1, epigenetics, GABRB2, HDAC inhibitors, Neurodegenerative Diseases, neuroinflammation, neuroscience, tau phosphorylation, Trichostatin ATrichostatin A for Alzheimer’s: 8 Core Genes, Unstable Binding
A 2026 PLOS One computational study linked Trichostatin A to 949 predicted…
-
3D FLAIR MRI, Alzheimer’s disease, Brain, brain aging, brain lymphatics, cerebrospinal fluid, cervical lymph nodes, cognition, glymphatic system, meningeal lymphatic vessels, Neurodegenerative Diseases, neuroimaging, neuroscience, parkinson’s diseaseBrain Lymphatic MRI Shows Aging-Linked Drainage Changes
A 2022 Nature Communications study used non-contrast 3D T2-FLAIR magnetic resonance imaging…
-
alpha-synuclein, Alzheimer’s disease, blood brain barrier, Brain, microplastics, Neurodegenerative Diseases, neuroinflammation, neuroscience, oxidative stress, parkinson’s diseaseMicroplastics and Parkinson’s Disease: 6 Plausible Brain-Risk Pathways
A 2026 mechanistic review linked microplastics to 6 proposed Alzheimer’s disease pathways…
-
Alzheimer’s disease, amyloid beta, blood brain barrier, Brain, cerebral blood flow, dementia biomarkers, Neurodegenerative Diseases, neuroscience, neurovascular unit, pericytesAlzheimer’s Neurovascular Unit Dysfunction May Start Before Amyloid
A 2026 review argues that neurovascular-unit dysfunction may precede amyloid-beta generation in…
-
A4 study, ADNI, Alzheimer’s disease, amyloid PET, blood biomarker, Brain, calibration, cognition, machine learning, negative predictive value, Neurodegenerative Diseases, p-tau217, plasma biomarkersAlzheimer’s Blood Biomarker Models Lose Rule-Out Power Across Cohorts
A 2026 ADNI/A4 validation study found that Alzheimer’s plasma-biomarker machine-learning models still…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
-
alpha-synuclein co-pathology, alpha-synuclein SAA, ALZAN cohort, Alzheimer’s disease, Brain, CSF biomarkers, lewy body dementia, memory clinic biomarkers, Neurodegenerative Diseases, neuroscience, RT-QuICAlpha-Synuclein SAA Detected 95% of Lewy Body Dementia in ALZAN
A 2026 ALZAN memory-clinic cohort found that cerebrospinal-fluid alpha-synuclein seed amplification assay…
-
Alzheimer’s disease, amygdala, blood biomarkers, Brain, cognition, cognitive impairment, dementia biomarkers, hippocampus, MRI radiomics, Neurodegenerative Diseases, neuroscience, olfactory dysfunction, pTau217Olfactory MRI Radiomics Link pTau217 to Alzheimer’s Cognition
A 2026 multi-cohort Alzheimer’s disease study found that MRI radiomics from the…
